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(IC)detector making use of gamma analysis (3%,3mm): 
measurement and simulationtimes were compared too. 
 
Results: The table shows a comparison of clinically 
significant DVH points from TPS dose distribution, MC 
simulation of the nominal plan and of TCS log file. 
 
 
In figure a comparison of TPS and MC planar dose distribution 
with 2DQA measurements is shown. In our protocol, if the 
passing rate (PR) is above 95% the field is accepted. If it is 
between 95 and 90% a justification must be added to the QA 
report to flag the field as accepted. A passing rate below 90% 
makes the field unacceptable. In the graph 27 fields 
belonging to 10 patients are analysed. MC has a PR always 
greater than 95% for every depth showing a good agreement 
with measurements. TPS results are always in the “grey” area 
between 90 and 95%. The execution time of a 2DQA with an 
array of ICs takes almost 1 hour and half; simulations, that 
can be performed in parallel, take 11 minutes on average. 
 
 
 
Conclusion: We realized a system to verify with an 
independent calculation algorithm both the nominal plan and 
the delivered one with the TPS dose distribution. This lets 
the user to estimate the effects on the dose distribution due 
to a different algorithm and due to delivery uncertainties of 
the machine. We proposed a method to drastically reduce 
2DQA verification time. Our suggestion is to substitute 
measurements with simulation that showed a very high 
accordance in terms of gamma PR (always above 95%); one 
field per patient may be measured at single depth as an 
additional safety check.  
[1] F Fracchiolla et al,'End to end' validation of a Monte Carlo 
code for independent dose calculation in a proton pencil 
beam scanning system Radand Onc, 115, S78–S79, 2015 
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Purpose or Objective: The treatment couches for Gantry2 
will support new head pieces for head and neck treatments, 
the BoS HeadframeTM. Thanks to their geometry and 
composition (a sandwich of thin carbon layers and light 
foam), they will increase the flexibility of planning, as they 
should only minimally disturb proton beams passing through 
it. Therefore there will be no restrictions in the deliverable 
gantry angles; posterior targets will be treated in supine 
position, thus increasing patient comfort, safety (especially 
for children under anesthesia) and the position accuracy (bite 
block will be used more often). We describe here the 
measurement of their Water Equivalent Range (WER) and 
homogeneity. 
 
Material and Methods: Mono-energetic scanned proton layers 
(12x20cm2) of 129 MeV up to 145 MeV were delivered through 
the head support, with the proton dose on exit being 
measured using a scintillating screen/CCD camera device 
approach. A reference set of measurements were first 
performed without the head support with 1 MeV discrete 
energy steps. The measurements were then repeated for 
three different positions (head, neck and shoulder) of the 
head support. A second set of measurements were performed 
with an energy step of 0.2 MeV for energies between 133-139 
MeV, to increase the measurement accuracy. For each 
acquisition, a 2D map of the maximum values among all the 
layers was generated, from which the WER of the head 
support in the different positions could be calculated by 
subtracting the measurements with and without the frame. 
WER homogeneity was calculated as the standard deviation of 
sub-regions of the 2D difference maximum value maps. CT 
images of the head supports were also imported in the TPS 
and converted to WER (via HU-Relative Proton Stopping 
Power calibration curve), to estimate if the planned WER 
corresponded to the measured values (with no need of 
synthetic CTs). 
 
Results: WER was found to be between 2.4mm and 7.2mm 
with an accuracy of 1.0mm or 0.5mm, depending on the 
measurements energy steps (respectively 1.0 MeV and 0.2 
MeV) (Fig). In the three different positions, WER in-
homogeneity was lower than 1.0mm (respectively 0.36mm, 
0.99mm and 0.40mm). The differences of WER between 
measured and TPS values were also below 0.5 mm (0.2 MeV 
step) and 1.4 mm (1 MeV step). 
 
 
 
Conclusion: The described method was accurate, fast and 
reproducible. The results on the thickness and homogeneity 
of the head frame show that it can be safely and accurately 
used in clinical operation and the first patients have already 
been treated. 
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Purpose or Objective: Accurate modeling of the MLC is 
necessary to achieve a clinically acceptable agreement 
between dose calculations and measurements in IMRT/VMAT 
treatment plans. The RayStation TPS uses several parameters 
to model a MLC but no specific procedure exists on how to 
perform measurements to optimize them. The aim of this 
work is to present a fast procedure to optimize the MLC 
parameters in RayStation v.4.5 and to assess the obtained 
MLC model. 
 
Material and Methods: A proper set of MLC-collimated fields 
was designed on a Varian Trilogy linear accelerator equipped 
with a Millennium 120 MLC. Dose profile scans of those fields 
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were taken in a motorized water phantom using small 
detectors (Razor stereotactic diode and PFD, IBA Dosimetry). 
In addition, MLC transmission was measured using a Farmer 
ion chamber. MLC model parameters (transmission, offset, 
leaf tip width, tongue-and-groove) were optimized to 
maximize the agreement between measurements and 
calculations. Model assessment was performed using a set of 
highly intensity-modulated MLC geometrical patterns, 
designed to enhance tongue-and-groove, transmission and 
offset/leaf-tip effects. For those fields, planar dosimetry was 
carried out with GafChromic EBT3 films. Clinical validation 
was performed evaluating TG-119 cases along with 25 DMLC 
and 10 VMAT clinical plans. Plan-specific quality assurance 
was performed with a 2D-array (MatriXX, IBA Dosimetry) and 
gamma-index metric was used to assess the agreement 
between planned and measured dose distributions. A 
2%/2mm criterion was used with both local (LN) and global 
(GN) normalization. 
 
Results: Optimized MLC parameters were: transmission 
0.018, position-offset 0.04cm, tongue-and-groove 0.05cm, 
leaf tip width 0.3cm. Average and standard deviation (SD) 
values of gamma index pass-rates were: for geometrical 
patterns: 92.8%, SD=5.1%(LN); 95.5%, SD=2.5%(GN). For TG-
119 plans: 97.1%, SD=4.4%(LN); 99.7%, SD=0.7%(GN). For 
DMLC clinical plans: 97.0%, SD=3.7% (LN); 98.8%, 
SD=2.6%(GN). For VMAT plans 90.1%, SD=4.0% (LN); 96.5%, 
SD=2.1% (GN). Critical regions dominated by tongue-and-
groove and rounded-leaf-tip effect showed a very good 
agreement between measurements and calculations (see 
Fig.1). 
 
 
Conclusion: Results demonstrate the followed procedure 
leads to a proper optimization of the MLC model in 
RayStation, leading to clinically acceptable gamma index 
pass-rates. The needed additional measurements can be 
easily integrated as a subset of the standard measurements 
required for the commissioning of the RayStation TPS. 
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Purpose or Objective: To compare dose-volume metrics 
calculated with the four-dimensional (4D) Monte Carlo (MC) 
and three-dimensional (3D) dose evaluation systems in 
dynamic tumor tracking (DTT) irradiation for lung or liver 
tumors. 
 
Material and Methods: Twenty patients with lung tumors and 
15 patients with liver tumors who underwent DTT irradiation 
using a gimbal-mounted linac were enrolled in this study. 
During computed tomography (CT) simulation, 4DCT under 
free breathing and exhale breath-hold CT were performed. 
Planning target volume (PTV) for DTT was calculated using 
the gross tumor volume (GTV) delineated on a reference CT 
scan (exhale phase in the 4DCT or exhale breath-hold CT) by 
adding asymmetric margins to compensate for possible errors 
due to the DTT. The 6 to 9 non-coplanar ports of the 6-MV X-
ray were set to each PTV. Doses were calculated for the 
reference CT using a commercially available treatment 
planning system (TPS). At the same time, 4DMC dose 
evaluation was performed for 10 respiratory phases of 4DCT 
using an in-house dose calculation system based on the MC 
algorithm, considering the gimbal rotation. The doses 
calculated for 10 phases were accumulated using deformable 
image registration software for the lung tumor patients, 
whereas mean values of the dose-volume metrics were 
evaluated for the liver tumor patients. The difference 
between the doses calculated with 4DMC (4D doses) and 
those calculated for the reference CT scan with TPS (3D 
doses) were investigated for the following dose-volume 
metrics: the percentage of dose that covers 95% of the GTV 
(GTV D95), the max dose received by the spinal cord (Cord 
max), the percentage of lung volume that received more 
than 20 Gy and 5 Gy irradiation (Lung V20 and Lung V5, 
respectively) in patients with lung tumors, and the mean 
dose and percentage of liver volume that received more than 
20 Gy irradiation (Liver mean and Liver V20, respectively) in 
patients with liver tumors. 
 
Results: The mean values of the dose-volume metrics for the 
4D doses were as follows: 94.1% (range, 83.8–99.7%) GTV D95, 
9.7 Gy (range, 1.8–22.0 Gy) Cord max, 4.9% (range, 1.9–
13.7%) Lung V20, 19.2% (range, 7.2–30.7%) Lung V5, 10.0 Gy 
(range, 5.2–15.2) Liver mean,15.5% (range, 8.2–27.7%) Liver 
V20 The mean differences in the dose-volume metrics for the 
3D and the 4D doses were as follows: 0.5% (range, -7.4–4.8%) 
GTV D95, 0.1 Gy (range, -2.5–1.8 Gy) Cord max, 0.1% (range, 
-0.8–1.4%) Lung V20, 0.3% (range, -1.6–2.1%) Lung V5, 0.1 Gy 
(range, -1.6–1.1 Gy) Liver mean, and -1.0% (range, -1.7–3.1%) 
Liver V20. There were no statistical significant differences in 
these dose-volume metrics evaluated by paired t-test. 
 
Conclusion: The 3D doses calculated with TPS for the target 
tumor and organs at risk were almost equal to those 
calculated with 4DMC. 3D dose could be used as a 
substitution for 4DMC calculation. However, the dose to the 
spinal cord was underestimated by a maximum of 2.5 Gy. 
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